Aquaculture Disease Control: 74% Tilapia Survival in 90 Days

Home 9 Case Studies and Results 9 Aquaculture Disease Control: 74% Tilapia Survival in 90 Days
Key results
74% survival in treated tank
Highest survival of 4 tanks
90-day clinical trial

Aquaculture disease control in a recirculating system

Aquaculture disease control is a particular challenge in a recirculating system, where the same water carries bacterial, fungal and parasitic disease from tank to tank. AquaVet Technologies ran a 90-day evaluation in a recirculating system of four 10 cubic metre tanks, each stocked with 300 hybrid tilapia, with infected fish held in disease reservoir tanks. A HydroFLOW® unit treated the incoming water to one healthy tank, Tank IV, before it reached the fish. After 90 days Tank IV had the highest survival of the four tanks, 74%, against 42% in reservoir Tank III, with lower bacterial counts and fewer infection symptoms.

The Challenge

  • Aquaculture disease control was difficult because recirculated water spread disease between tanks
  • Disease reservoir tanks contained infected tilapia
  • Bacterial, fungal and parasitic pathogens could travel through the water
  • Untreated tanks suffered higher mortality
  • Chemical treatments add cost and environmental impact

The Solution

  • Unit installed: one HydroFLOW® unit
  • Installation point: incoming water supply to Tank IV, a healthy control tank
  • Tanks: four 10 cubic metre tanks, 300 hybrid tilapia in each
  • Trial: 90 days, with clinical fish evaluation and bacterial analysis of water samples

The trial was designed to test aquaculture disease control at the point where water enters a tank. Recirculated water from the system reached Tank IV only after passing the HydroFLOW® unit. Fish were evaluated clinically through the 90 days, water samples were taken for bacterial analysis, and survival was compared across all four tanks at the end.

Key Outcomes

R

74% survival in the treated tank after 90 days

R

90-day clinical evaluation

R

74% against 42% in disease reservoir Tank III

R

Lower bacterial counts and fewer infection symptoms

Independent Verification

All results in this study were measured and verified by third-party facilities managers and technical staff.

Summary

AquaVet Technologies' 90-day trial found that the tilapia tank fed HydroFLOW®-treated water had the highest survival of four tanks, 74%, with lower bacterial counts, lower mortality and fewer infection symptoms. For recirculating aquaculture, where one infected tank can seed the rest, the useful point is where the treatment sat: on the water entering the tank, so it was treated before it reached the fish.

Ready to see more?

Ready to explore sustainable water treatment?

Get in touch to find out how HydroFLOW® can work for you.

© 2026 Hydropath Technology Ltd. All rights reserved